BCHE and Alzheimer disease: Alzheimer’s disease (AD) is a fatal dementia that, according to the cholinergic hypothesis, results from low levels of neurotransmitters caused by cholinesterase, which hydrolyze acetylcholine, making cholinesterase inhibitors suitable therapeutics [5,6].